SEC Form 4 · accession 0001179110-15-004043
ABBOTT LABORATORIES · ABT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert E Funck
Officer — Vice President, Controller
Period of report
Feb 27, 2015
Accepted (ET)
Mar 3, 2015 · 5:15 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000001800
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common shares without par value | Feb 27, 2015 | F | 2,922 | $47.61 | D | 71,448 | D | |
| Common shares without par valueF1 | holding | — | — | — | 15,891 | I | Profit Sharing Trust | |
| Common shares without par valueF2 | holding | — | — | — | 500 | I | By daughter | |
| Common shares without par valueF2 | holding | — | — | — | 500 | I | By daughter |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Balance in the Abbott Laboratories Stock Retirement Trust as of February 27, 2015.
- F2The reporting person disclaims beneficial ownership of all securities held by his daughter.